Last edition
News about "Japan"
Mochida Seeks Japan's Approval for Tocilizumab Biosimilar in Partnership with AYUMI
This application is based on the results of a Phase I clinical study conducted in Japan with 110 healthy adults and a Phase III clinical study conducted in Japan with 368 patients with rheumatoid arthritis.
Japan | 28/03/2025 | By Abha
Renalys Pharma Completes Patient Enrollment for Phase III Trial of Sparsentan in Japan
In April 2024 Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.
Japan | 01/02/2025 | By Abha | 102
Eisai completes construction of new injection/research building at Kawashima Industrial Park, Japan
Eisai Medicine Innovation Technology Solutions will be Eisai's global base for formulation and modality research
Japan | 06/10/2022 | By Sudeep Soparkar | 568
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy